earnings
AB
NASDAQ · ABEO
Abeona Therapeutics Inc.
Healthcare · Biotechnology
$4.17
Down-$1.66 (-39.69%)
Updated Nov 9, 2026, 4:37 PM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 277.46M
- P/E ratio
- 3.37
- Dividend yield
- 0.00%
- 52-week range
- $3.91 – $7.65
- Volume
- 1.05M
- Avg. volume
- 1.15M
Price performance · ABEO
ABEO price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 6, 2026
ABEO closed at $4.17 after 20 trading sessions, down 14.90% for the selected period.
- Last close
- $4.17
- Period change
- -14.90%
- Period low
- $3.91
- Period high
- $4.90
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | $4.02 | $4.265 | $3.95 | $4.17 | 1.05M |
| Nov 5, 2026 | $4.19 | $4.25 | $3.91 | $3.91 | 1.55M |
| Nov 4, 2026 | $4.36 | $4.42 | $4.19 | $4.22 | 881.73K |
| Nov 3, 2026 | $4.27 | $4.4001 | $4.20 | $4.25 | 1.12M |
| Nov 2, 2026 | $4.43 | $4.4559 | $4.16 | $4.25 | 1.01M |
| Oct 30, 2026 | $4.50 | $4.53 | $4.305 | $4.35 | 783.43K |
| Oct 29, 2026 | $4.54 | $4.73 | $4.4701 | $4.56 | 874.33K |
| Oct 28, 2026 | $4.46 | $4.58 | $4.44 | $4.55 | 618.15K |
| Oct 27, 2026 | $4.33 | $4.495 | $4.30 | $4.45 | 663.68K |
| Oct 26, 2026 | $4.39 | $4.41 | $4.305 | $4.31 | 426.58K |
| Oct 23, 2026 | $4.42 | $4.435 | $4.29 | $4.40 | 797.29K |
| Oct 22, 2026 | $4.46 | $4.61 | $4.38 | $4.47 | 717.81K |
| Oct 21, 2026 | $4.62 | $4.67 | $4.50 | $4.51 | 643.56K |
| Oct 20, 2026 | $4.43 | $4.645 | $4.40 | $4.60 | 1.39M |
| Oct 19, 2026 | $4.47 | $4.49 | $4.32 | $4.41 | 986.05K |
| Oct 16, 2026 | $4.66 | $4.66 | $4.39 | $4.43 | 819.51K |
| Oct 15, 2026 | $4.39 | $4.785 | $4.35 | $4.65 | 1.38M |
| Oct 14, 2026 | $4.48 | $4.51 | $4.28 | $4.36 | 1.77M |
| Oct 13, 2026 | $4.88 | $4.88 | $4.505 | $4.52 | 1.98M |
| Oct 12, 2026 | $4.93 | $4.945 | $4.855 | $4.90 | 758.41K |
Latest ABEO news
The latest Smart Investors Daily articles mentioning ABEO.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

